- Home
- SENS vs PACB Comparison
SENS vs PACB Comparison
Compare SENS & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENS
- PACB
- Stock Information
- Founded
- SENS 1996
- PACB 2000
- Country
- SENS United States
- PACB United States
- Employees
- SENS N/A
- PACB N/A
- Industry
- SENS Industrial Machinery/Components
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- SENS Industrials
- PACB Industrials
- Exchange
- SENS Nasdaq
- PACB Nasdaq
- Market Cap
- SENS 396.0M
- PACB 364.2M
- IPO Year
- SENS N/A
- PACB 2010
- Fundamental
- Price
- SENS $0.52
- PACB $0.96
- Analyst Decision
- SENS Strong Buy
- PACB Buy
- Analyst Count
- SENS 2
- PACB 9
- Target Price
- SENS $2.00
- PACB $2.34
- AVG Volume (30 Days)
- SENS 6.9M
- PACB 9.9M
- Earning Date
- SENS 05-08-2025
- PACB 05-08-2025
- Dividend Yield
- SENS N/A
- PACB N/A
- EPS Growth
- SENS N/A
- PACB N/A
- EPS
- SENS N/A
- PACB N/A
- Revenue
- SENS $23,682,000.00
- PACB $152,357,000.00
- Revenue This Year
- SENS $60.14
- PACB $4.67
- Revenue Next Year
- SENS $36.55
- PACB $19.09
- P/E Ratio
- SENS N/A
- PACB N/A
- Revenue Growth
- SENS 1.64
- PACB N/A
- 52 Week Low
- SENS $0.25
- PACB $0.85
- 52 Week High
- SENS $1.40
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- SENS 39.02
- PACB 41.28
- Support Level
- SENS $0.52
- PACB $0.85
- Resistance Level
- SENS $0.54
- PACB $1.15
- Average True Range (ATR)
- SENS 0.04
- PACB 0.09
- MACD
- SENS -0.00
- PACB 0.00
- Stochastic Oscillator
- SENS 16.29
- PACB 34.45
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.